Development of a core outcome set for hypertensive intracerebral hemorrhage in clinical trials of traditional Chinese medicine: a study protocol

BACKGROUND: Intracerebral hemorrhage (ICH) is a devastating disease, its mortality and disability rate are high. In China, hypertensive intracerebral hemorrhage (HICH) is responsible for 75% of all the cases of primary ICH. A lot of randomized controlled trials (RCTs) of traditional Chinese medicine...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Min, Lu, Yan, Liang, Xiao, Tong, Chenguang, Wang, Jian, Tang, Jun, Yang, Jian, Wang, Min, Jiao, Weiwei, Du, Wanqing, Wei, Jingjing, Zeng, Zixiu, Xu, Zhenmin, Chen, Qian, Lei, Lin, Liao, Xing, Zhang, Yunling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559838/
https://www.ncbi.nlm.nih.gov/pubmed/36224599
http://dx.doi.org/10.1186/s13063-022-06801-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559838/
https://www.ncbi.nlm.nih.gov/pubmed/36224599
http://dx.doi.org/10.1186/s13063-022-06801-z

Ejemplares similares